Company intelligence / Profile preview
Elasmogen Ltd
Aberdeen, Scotland, United Kingdomelasmogen.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
No clinical trial data published yet; pipeline assets are in late-stage pre-clinical development with promising first-in-class drug conjugates and bi-specific products. The lead oncology program partnered with Almac Discovery targets ROR1 using a soloMER-drug conjugate approach. The autoimmune portfolio includes novel orphan therapies for difficult-to-treat inflammatory eye diseases.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Proprietary biologics called soloMERs™ derived from shark immune system molecules, which are antibody-like but smaller and more stable.
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Almac Discovery Ltd for oncology drug candidate developmentFeldan Therapeutics collaboration with Amgen to develop intracellular biologics combining Feldan Shuttle and Elasmogen’s soloMER technology
Beyond the preview
Go deeper on Elasmogen Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elasmogen Ltd.